Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Evaluation of Flibanserin: Science and Advocacy at the FDA. JAMA 2015 Sep 01;314(9):869-70

Date

07/07/2015

Pubmed ID

26148201

DOI

10.1001/jama.2015.8405

Scopus ID

2-s2.0-84940749847 (requires institutional sign-in at Scopus site)   41 Citations

Author List

Gellad WF, Flynn KE, Alexander GC

Author

Kathryn Eve Flynn PhD Vice Chair, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Advisory Committees
Benzimidazoles
Consumer Advocacy
Depression
Drug Approval
Female
History, 21st Century
Humans
Libido
Sexual Dysfunctions, Psychological
United States
United States Food and Drug Administration